Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZ) Assets: 2020-2025

Historic Assets for Core Scientific (CORZ) over the last 5 years, with Sep 2025 value amounting to $2.3 billion.

  • Core Scientific's Assets rose 149.06% to $2.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.3 billion, marking a year-over-year increase of 149.06%. This contributed to the annual value of $1.6 billion for FY2024, which is 124.50% up from last year.
  • As of Q3 2025, Core Scientific's Assets stood at $2.3 billion, which was up 16.07% from $2.0 billion recorded in Q2 2025.
  • Core Scientific's 5-year Assets high stood at $2.7 billion for Q1 2022, and its period low was $347.1 million during Q3 2021.
  • In the last 3 years, Core Scientific's Assets had a median value of $814.0 million in 2024 and averaged $1.2 billion.
  • In the last 5 years, Core Scientific's Assets soared by 16,258,993.33% in 2021 and then plummeted by 71.89% in 2023.
  • Over the past 5 years, Core Scientific's Assets (Quarterly) stood at $2.4 billion in 2021, then slumped by 66.88% to $807.7 million in 2022, then declined by 11.83% to $712.2 million in 2023, then skyrocketed by 124.50% to $1.6 billion in 2024, then skyrocketed by 149.06% to $2.3 billion in 2025.
  • Its last three reported values are $2.3 billion in Q3 2025, $2.0 billion for Q2 2025, and $1.6 billion during Q1 2025.